Kidney cancer features in younger patients
Part of Cancer, Kidney & urinary clinical trials.
This study looks at kidney cancer in people under 40 to understand its characteristics and how it behaves. It may help doctors tailor treatment for younger patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are under 40 years old.
- You have been diagnosed with kidney cancer (renal cell carcinoma).
- You are eligible to receive treatment for your kidney cancer.
- You have not had another type of cancer (other than kidney cancer).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at what makes people with kidney cancer decide to join clinical trials. By participating, you'll help researchers understand how to make future studies easier for patients to access and complete.
This study tracks people with early-stage kidney cancer (tumors smaller than 4 cm) who are treated with radiofrequency ablation, a procedure that uses heat to destroy cancer cells. The goal is to see how well this treatment works in real-world practice.
This research study helps doctors understand inherited kidney cancers and related conditions that run in families. Researchers collect medical information and blood samples to identify genetic causes and improve how these conditions are diagnosed and treated.
This study looks at colorectal cancer in younger patients who wouldn't normally be screened. Researchers want to understand how this cancer develops in people under the typical screening age.
This study tests whether closely monitoring small kidney tumors (less than 4 cm) with regular imaging is a safe and effective option for people who cannot or choose not to have immediate treatment. It involves a biopsy at the start to confirm the tumor type.
This study looks at patients with kidney cancer that hasn't spread and is considered high-risk. It uses a registry to learn more about these patients to improve future care.
Hear when a new Clinicopathologic Characters of Renal Cell Carcinoma in Young Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.